A Phase 1, Open-Label, Dose Escalation, Safety, and Tolerability Study of INCB054828 in Subjects with Advanced Malignancies June 15, 2017 Sponsor Incyte Protocol Number Incyte INCB 54828-101 To Learn More Call 201-510-0910